SurModics, Inc. (SRDX)

42.98 +0.00%

SurModics, Inc. (SRDX) is currently trading at $42.98. This represents a gain of 0% from the previous session. With a market capitalization of $0.61B, SRDX is a key component of the Health Care sector. Investors looking to trade SRDX should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade SRDX commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, SurModics, Inc. (SRDX) shows a bullish trend. Analysts are watching the 0.00 level closely.

Fundamentals
Mkt Cap0.61B
P/E Ratio0.0000
Volume0
Others Watching (By Market Cap)
VIR
Vir Biotechnolo $10.47
+10.43% HCSG
Healthcare Serv $21.23
-0.84% TRVI
Trevi Therapeut $11.56
+2.66% CRVS
Corvus Pharmace $18.05
+1.26% AVAH
Aveanna Healthc $7.12
+0.85%
60-Day Technical Chart
Advanced Charting

Need more indicators for SRDX? Use the world's #1 platform.

Open SRDX on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $43
Metric SRDX
+0.00% 		INTC
-0.88% 		PYPL
-0.38% 		CSGP
-6.86%
Price $42.98 $45.67 $46.77 $45.78
Mkt Cap $0.61B $228.77B $44.06B $19.42B
- View → View → View →
Latest Headlines
Surmodics stock rises after FTC indicates no appeal of merger ruling Investing.com • Nov 17, 2025 Surmodics surges after court denies injunction to block sale to GTCR (SRDX:NASDAQ) Seeking Alpha • Nov 11, 2025 Surmodics (SRDX) Surges After Court Clears Path for GTCR Acquisi GuruFocus • Nov 11, 2025 Here's Why You Should Retain Surmodics Stock in Your Portfolio Now Yahoo Finance • Mar 18, 2025 Surmodics Stock Soars Amid Positive Registry Study Results and Court Ruling StocksToTrade • Nov 11, 2025
● Gemini Agentic AI Analyst Insight for SRDX
Market Education
View All Articles →
External Research